NeuroOne Medical investor Brian Pratt discloses stake

Brian Pratt, a more-than-10% owner of NeuroOne Medical Technologies Corp, reported beneficial ownership of 1,085,934 shares of common stock.

Rhea-AI Filing Summary

Brian Pratt, a more-than-10% owner of NeuroOne Medical Technologies Corp, reported beneficial ownership of 1,085,934 shares of common stock. These shares are held in a joint account with his spouse, reflecting direct beneficial ownership; the filing records existing holdings only, with no new buy or sell transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pratt Brian

Role 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock F1	--	--	--

Holdings After Transaction: Common Stock — 1,085,934 shares (Direct)

Footnotes (1)

1. F1. These shares of common stock are held in a joint account by Brian Pratt and his spouse, Barbara Pratt.

Key Figures

Common shares beneficially owned: 1085934.0000 shares Reported holding entry date: 2026-07-10 Reported buy or sell transactions: 0

3 metrics

Common shares beneficially owned 1085934.0000 shares Direct beneficial ownership reported by Brian Pratt as of the Form 3 event date

Reported holding entry date 2026-07-10 Date associated with the reported common stock holding

Reported buy or sell transactions 0 Form 3 reflects existing holdings only, with no purchase or sale activity

Key Terms

beneficial ownership, Form 3, joint account

3 terms

beneficial ownership financial

"Initial statement of beneficial ownership of common stock by a ten percent owner."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Form 3 regulatory

"Initial statement of beneficial ownership on Form 3."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

joint account financial

"Shares are held in a joint account by Brian Pratt and his spouse."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does NeuroOne (NMTC) insider Brian Pratt report in this Form 3?

Brian Pratt reports beneficial ownership of 1,085,934 NeuroOne common shares. The stake is disclosed as his initial statement of ownership as a more-than-10% shareholder, giving investors visibility into a significant existing holding rather than a new transaction.

How many NeuroOne (NMTC) shares does Brian Pratt beneficially own?

Brian Pratt beneficially owns 1,085,934 shares of NeuroOne common stock. This entire position is reported as directly owned and represents a significant stake that qualifies him as a more-than-10% owner under Section 16 reporting rules.

How are Brian Pratt's NeuroOne (NMTC) shares held according to the Form 3?

The 1,085,934 NeuroOne shares are held in a joint account by Brian Pratt and his spouse, Barbara Pratt. This joint-account structure is disclosed in a footnote, clarifying the nature of their shared beneficial ownership of the common stock.

Does Brian Pratt's NMTC Form 3 show any recent stock purchases or sales?

No, the Form 3 shows no buy or sell transactions. It records Pratt’s existing beneficial ownership of 1,085,934 common shares, with zero reported purchase or sale entries, serving purely as an initial ownership disclosure rather than a trading report.

Are any derivative securities reported for Brian Pratt in the NMTC Form 3?

No, the filing reports no derivative securities such as options or warrants. Only common stock holdings are listed, indicating that Pratt’s disclosed Section 16 position in NeuroOne currently consists solely of directly held common shares in a joint account.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/14/2026 - 04:28 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pratt Brian

(Last) (First) (Middle)

5950 BERKSHIRE LANE, SUITE 800

(Street)

DALLAS TEXAS 75225

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/10/2026

3. Issuer Name and Ticker or Trading Symbol
NEUROONE MEDICAL TECHNOLOGIES Corp [ NMTC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,085,934	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares of common stock are held in a joint account by Brian Pratt and his spouse, Barbara Pratt.

	/s/ Brian Pratt	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)